Yizhen Pang

3.3k total citations · 2 hit papers
69 papers, 2.4k citations indexed

About

Yizhen Pang is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Yizhen Pang has authored 69 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 35 papers in Cancer Research and 28 papers in Surgery. Recurrent topics in Yizhen Pang's work include Peptidase Inhibition and Analysis (59 papers), Protease and Inhibitor Mechanisms (34 papers) and Cardiac Structural Anomalies and Repair (25 papers). Yizhen Pang is often cited by papers focused on Peptidase Inhibition and Analysis (59 papers), Protease and Inhibitor Mechanisms (34 papers) and Cardiac Structural Anomalies and Repair (25 papers). Yizhen Pang collaborates with scholars based in China, Singapore and United States. Yizhen Pang's co-authors include Haojun Chen, Long Sun, Liang Zhao, Hua Wu, Qin Lin, Bing Hao, Zuoming Luo, Long Zhao, Qihang Shang and Chengrong Xie and has published in prestigious journals such as Journal of Clinical Investigation, Radiology and Clinical Cancer Research.

In The Last Decade

Yizhen Pang

67 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer

2020 398 citations Haojun Chen, Yizhen Pang et al. European Journal of Nuclear Medicine and Molecular Imaging profile →
Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review

2022 128 citations Liang Zhao, Jianhao Chen et al. Theranostics profile →

Peers

Countries citing papers authored by Yizhen Pang

Since Specialization

Citations

This map shows the geographic impact of Yizhen Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yizhen Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yizhen Pang more than expected).

Fields of papers citing papers by Yizhen Pang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yizhen Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yizhen Pang. The network helps show where Yizhen Pang may publish in the future.

Co-authorship network of co-authors of Yizhen Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Yizhen Pang. A scholar is included among the top collaborators of Yizhen Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yizhen Pang. Yizhen Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical and pilot clinical evaluation of novel dual-modality pet/fluorescence probes targeting FAP for accurate tumor margin delineation 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·Liang Zhao, Yizhen Pang, Daqiang Xu, Jianhao Chen, Shan Yu, Dan Ruan, (unknown), Zhenyu Wu, Guoqiang Su, Hua Wu, Lin Ai, Long Sun, Di Fan, Haojun Chen	0
2	FAP-targeted PET/CT imaging in patients with breast cancer from a prospective bi-center study: insights into diagnosis and clinic management 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·Wei Guo, Weizhi Xu, Tinghua Meng, Chunlei Fan, Hao Fu, Yizhen Pang, Liang Zhao, Long Sun, (unknown), Yanjun Mi, Xinlu Wang, Haojun Chen	4
3	177Lu-LNC1004 Radioligand Therapy in Patients with End-stage Metastatic Cancers: A Single-Center, Single-Arm, Phase II Study 2025 ·Clinical Cancer Research ·Hao Fu, (unknown), Liang Zhao, (unknown), Weizhi Xu, (unknown), (unknown), Yizhen Pang, Wei Guo, (unknown), (unknown), Hua Wu, Jingjing Zhang, Xiaoyuan Chen, Haojun Chen	13
4	68Ga-NK224 PET/CT for Noninvasive Evaluation of PD-L1 Expression and Intertumor Heterogeneity: A Translational Exploratory Study 2025 ·Clinical Cancer Research ·Liang Zhao, Yizhen Pang, Yi Ding, (unknown), Jianyang Fang, (unknown), (unknown), Yaqing Dai, Hui Zhou, Hao Fu, Wei Guo, Long Sun, Hua Wu, Shan Zhong, Qin Lin, Haojun Chen	3
5	Enhanced Detection of Early Pulmonary Fibrosis Disease Using ⁶⁸Ga-FAPI-LM3 PET 2024 ·Molecular Pharmaceutics ·Jianhao Chen, (unknown), Yaqing Dai, Yangfan Zhou, Yizhen Pang, Hua Wu, Long Sun, Guoqiang Su, (unknown), Liang Zhao, Haojun Chen	3
6	⁶⁸Ga-FAPI-46 PET/CT in the evaluation of gliomas: comparison with ¹⁸F-FDG PET/CT and contrast-enhanced MRI 2024 ·Theranostics ·Dan Ruan, (unknown), Chengkun Han, (unknown), (unknown), Liang Zhao, Yizhen Pang, Changjing Zuo, (unknown), (unknown), Guowei Tan, (unknown), Haojun Chen	4
7	68Ga-MY6349 PET/CT imaging to assess Trop2 expression in multiple types of cancer 2024 ·Journal of Clinical Investigation ·Haojun Chen, Liang Zhao, Yizhen Pang, Jiyun Shi, (unknown), (unknown), Jianhao Chen, Hao Fu, (unknown), (unknown), (unknown), (unknown), Hua Wu, Zhanxiang Wang, Fan Wang	13
8	Development of [177Lu]Lu-LNC1010 for peptide receptor radionuclide therapy of nasopharyngeal carcinoma 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·Jianhao Chen, Yizhen Pang, (unknown), Yangfan Zhou, Qicong Luo, Hua Wu, Changjing Zuo, Jingjing Zhang, Qin Lin, Xiaohong Chen, Liang Zhao, Haojun Chen	2
9	Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study 2023 ·Clinical Cancer Research ·Hao Fu, (unknown), Tianzhi Zhao, Hongjian Wang, (unknown), Weizhi Xu, Yizhen Pang, Wei Guo, Long Sun, Hua Wu, Peng‐Fei Xu, (unknown), Jingjing Zhang, Xiaoyuan Chen, Haojun Chen	56
10	Identification of isolated hepatic sarcoidosis with [18F]FDG and [68 Ga]Ga-FAPI PET/CT 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·Yizhen Pang, Peipei Wang, Weizhi Xu, (unknown), Haojun Chen	2
11	Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer 2023 ·PET Clinics ·Liang Zhao, Yizhen Pang, Long Sun, Qin Lin, Hua Wu, Haojun Chen	2
12	68Ga-FAPI PET/CT detected non-FDG-avid bone metastases in breast cancer 2022 ·European Journal of Nuclear Medicine and Molecular Imaging ·Qihang Shang, Bing Hao, Weizhi Xu, Tinghua Meng, Yizhen Pang, Long Sun, Haojun Chen	10
13	Comparison of [68Ga]Ga-FAPI and [18F]FDG uptake in patients with gastric signet-ring-cell carcinoma: a multicenter retrospective study 2022 ·European Radiology ·Haojun Chen, Yizhen Pang, Junpeng Li, Fei Kang, Weizhi Xu, Tinghua Meng, Qihang Shang, Jun Zhao, Yihui Guan, Hua Wu, Fang Xie, Jing Wang, Long Sun	39
14	PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using⁶⁸Ga-FAP-2286: Comparison with¹⁸F-FDG and⁶⁸Ga-FAPI-46 in a Single-Center, Prospective Study 2022 ·Journal of Nuclear Medicine ·Yizhen Pang, Liang Zhao, Tinghua Meng, Weizhi Xu, Qin Lin, Hua Wu, Jingjing Zhang, Xiaohong Chen, Long Sun, Haojun Chen	71
15	Increased 68Ga-FAPI Uptake in Ankylosing Spondylitis in a Patient With Rectal Cancer 2021 ·Clinical Nuclear Medicine ·(unknown), Long Zhao, Yizhen Pang, Qihang Shang, Haojun Chen	16
16	Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of⁶⁸Ga-Labeled FAPI Dimer 2021 ·Journal of Nuclear Medicine ·Liang Zhao, Bo Niu, Jianyang Fang, Yizhen Pang, (unknown), Chengrong Xie, Long Sun, Xianzhong Zhang, Zhide Guo, Qin Lin, Haojun Chen	114
17	Comparison of ⁶⁸Ga-FAPI and ¹⁸F-FDG Uptake in Gastric, Duodenal, and Colorectal Cancers 2020 ·Radiology ·Yizhen Pang, Liang Zhao, Zuoming Luo, Bing Hao, Hua Wu, Qin Lin, Long Sun, Haojun Chen	197
18	Comparison of 68Ga-FAPI and 18F-FDG PET/CT in a Patient With Cholangiocellular Carcinoma 2020 ·Clinical Nuclear Medicine ·Yizhen Pang, Bing Hao, Qihang Shang, Long Sun, Haojun Chen	24
19	Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Haojun Chen, Liang Zhao, Dan Ruan, Yizhen Pang, Bing Hao, Yaqing Dai, Xiurong Wu, Wei Guo, Chunlei Fan, Jingxun Wu, Weipeng Huang, Qin Lin, Long Sun, Hua Wu	172
20	[18F]FDG and [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of tuberculous lesions 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Bing Hao, Xiurong Wu, Yizhen Pang, Long Sun, Hua Wu, Weipeng Huang, Haojun Chen	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact